查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1794621

全球超音波设备市场

Phacoemulsification Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球超音波市场规模将达到 27 亿美元

全球超音波设备市场规模预计在2024年达到21亿美元，预计在2024-2030年的分析期内将以4.3%的复合年增长率增长，到2030年将达到27亿美元。超音波乳化白内障吸除耗材是本报告分析的细分市场之一，预计其复合年增长率将达5.1%，到分析期末将达到18亿美元。超音波乳化白内障吸除系统细分市场在分析期间的复合年增长率预计为2.8%。

美国市场规模估计为 5.817 亿美元，中国市场预计复合年增长率为 8.0%

美国超音波设备市场规模预计2024年达到5.817亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到5.684亿美元，2024年至2030年的复合年增长率为8.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.7%和3.4%。在欧洲，预计德国市场的复合年增长率为2.5%。

全球超音波市场—主要趋势与驱动因素摘要

为什么全球对超音波设备的需求不断成长？

由于白内障盛行率不断上升，尤其是在老化社会，全球对超音波术设备的需求持续稳定成长。白内障是全球视力障碍和失明的主要原因之一，而超音波吸除术因其微创、恢復快、成功率高，已成为白内障手术的黄金标准。老龄人口的不断增长，尤其是在北美、欧洲和亚太部分地区，推动了对高效、安全、可靠的白内障治疗的需求。各国政府和医疗体係正在大力投资眼科基础设施，以应对日益加重的患者负担，尤其是在那些以减少可预防失明为公共卫生任务的国家。此外，患者意识的提升和手术效果的改善，促使超音波乳化白内障吸除术迅速取代传统的超音波白内障摘除术。现代超音波吸除系统带来的便利性和精准性，加上新兴市场可支配收入的不断增长和医疗保险覆盖率的提高，进一步推动了这些先进设备的广泛应用。此外，慈善和非政府组织主导的倡议在将超音波技术引入服务不足地区、拓宽市场基础方面发挥关键作用。随着全球继续关註生活品质和功能寿命，人们对视觉健康的兴趣预计将进一步加速。

科技进步如何重新定义眼科手术的精确度？

超音波和抽吸设备的技术创新大大提高了手术精确度、安全性和患者预后。最新设备具有先进的流体系统、即时术中回馈和能量调节功能，可最大限度地减少热损伤并提高晶状体摘除效率。向微切口白内障手术 (MICS) 的转变带来了对更紧凑、更精密的牙科手机和机器的需求，这些手机和机器可在不影响手术控制的情况下进行更小的切口。扭转超音波技术、智慧抽吸控制和整合光同调断层扫瞄(OCT) 等创新彻底改变了白内障手术的实施方式。现在许多系统都提供基于晶状体硬度、患者眼部解剖结构和外科医生偏好的可自订设置，从而优化预后并减少併发症。触控萤幕介面和云端连接整合支援即时数据追踪和手术性能分析，增强了手术培训和标准化。此外，飞秒雷射辅助白内障手术 (FLACS) 的兴起，透过提高水晶体碎裂和撕囊的精准度，补充了超音波乳化白内障吸除术和抽吸术。业内公司正大力投入研发，旨在使系统更符合人体工学、节能高效、反应速度更快。这些创新不仅改善了临床疗效，也为新一代外科医师带来了设备的易用性。随着该领域的不断发展，超音波超音波乳化白内障吸除系统将变得更加智慧、创伤更小，并能根据每例手术的具体需求进行客製化。

医疗保健基础设施和外科手术培训在市场渗透中将发挥什么作用？

超音波系统的广泛应用在很大程度上取决于熟练眼科医师的供应和医疗基础设施的品质。在高所得国家，由于普遍能获得最先进的手术设备，超音波乳化白内障吸除术几乎完全取代了超音波摘除术。然而，在许多中低收入国家，由于缺乏训练有素的外科医生和设备不足的手术中心，超音波系统的广泛应用仍然有限。为了弥补这一差距，一些製造商和非营利组织正致力于透过全球推广计画开展教育和技能提升。结构化的训练模组、虚拟实境模拟器和现场手术研讨会正在帮助新一代眼科医生掌握超音波技术。同时，新兴国家门诊手术中心和私立眼科医院的激增，也催生了对高品质、高性价比手术系统的新需求。保险覆盖范围和包含白内障手术的政府资助医疗计画也正在增加患者数量，并鼓励医疗机构投资于超音波系统。此外，手术通讯协定和认证要求的标准化也促使越来越多的医院购买先进设备，以达到国际医疗标准。随着全球白内障失明负担的日益加重，提升手术能力和临床医生的专业技能对于这些技术的广泛应用至关重要。随着对医疗保健服务和技能发展的有针对性的投资，许多尚未开发的市场有望加速成长。

推动超音波市场成长的主要动力有哪些？

超音波市场的成长受到多种因素的驱动，这些因素与技术成熟度、人口结构变化以及不断发展的医疗服务模式有关。关键驱动因素包括全球人口快速老化，这导致老龄化性白内障盛行率上升，从而增加了对外科手术的需求。同时，设备功能的不断进步，例如改进的流体动态、即时手术分析和自适应能量输送系统，正在显着改善手术效果和患者安全。外科医师对微创技术和精密器械的日益偏好，进一步巩固了超音波乳化超音波作为白内障摘除术首选方法的地位。在医疗服务方面，独立眼科诊所、门诊手术中心和专科眼科网络的扩张，正在推动对紧凑、便携和扩充性手术系统的需求。消费者行为也发挥关键作用，患者越来越要求更快的康復时间、高清视觉效果和雷射辅助客製化。印度和中国等国政府资助的白内障根除项目，加上西方国家结构化的报销框架，使得这些先进的系统在经济上可行且易于普及。此外，选择性白内障手术的兴起以及白内障手术向二级和农村医疗中心的扩展，为器械製造商开闢了新的途径。最后，全球外科培训和器材法规的协调一致正在缩短新技术的上市时间，刺激竞争性创新，并增加跨地区更广泛产品的供应。

部分

产品（超音波耗材、超音波系统）；最终用户（医院最终用户、诊所最终用户、研究所最终用户）

受访公司范例

  • Alcon
  • Appasamy Associates
  • Bausch+Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • DORC Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos（a Nikon company）
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP37719

Global Phacoemulsification Devices Market to Reach US$2.7 Billion by 2030

The global market for Phacoemulsification Devices estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Phacoemulsification Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Phacoemulsification Systems segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$581.7 Million While China is Forecast to Grow at 8.0% CAGR

The Phacoemulsification Devices market in the U.S. is estimated at US$581.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$568.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Phacoemulsification Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Phacoemulsification Devices Rising Across the Globe?

The global demand for phacoemulsification devices is witnessing a steady surge due to the rising prevalence of cataracts, particularly among the aging population. Cataracts remain one of the leading causes of visual impairment and blindness globally, and phacoemulsification has become the gold standard in cataract surgery due to its minimally invasive nature, faster recovery time, and high success rate. The increasing geriatric demographic, especially in regions like North America, Europe, and parts of Asia-Pacific, has driven the need for efficient, safe, and reliable cataract treatment options. Governments and healthcare systems are investing significantly in ophthalmic care infrastructure to manage the growing patient burden, particularly in countries with public health mandates to reduce preventable blindness. Moreover, increased patient awareness and the accessibility of better surgical outcomes are contributing to the rapid adoption of phacoemulsification over traditional extracapsular cataract extraction methods. The convenience and precision offered by modern phacoemulsification systems, combined with rising disposable incomes and greater availability of health insurance in emerging markets, have further encouraged the uptake of these advanced devices. Additionally, philanthropic and NGO-led initiatives are playing a significant role in bringing phacoemulsification technologies to underserved areas, broadening the market reach. This increased focus on visual health is expected to accelerate further with continued global emphasis on quality of life and functional longevity.

How Are Technological Advancements Redefining Surgical Precision in Ophthalmology?

Technological innovations in phacoemulsification devices are dramatically improving surgical precision, safety, and patient outcomes. Modern devices now come equipped with advanced fluidics systems, real-time intraoperative feedback, and enhanced energy modulation capabilities that minimize thermal damage and improve lens removal efficiency. The shift toward microincision cataract surgery (MICS) has created a demand for more compact and sophisticated handpieces and machines that facilitate smaller incisions without compromising surgical control. Innovations such as torsional ultrasound technology, intelligent aspiration control, and integrated optical coherence tomography (OCT) have transformed how cataract surgeries are performed. Many systems now offer customizable settings based on lens hardness, patient eye anatomy, and surgeon preferences, resulting in optimized outcomes with reduced complications. Integration of touchscreen interfaces and cloud connectivity allows real-time data tracking and surgical performance analysis, which enhances both procedural training and standardization. Furthermore, the rise of femtosecond laser-assisted cataract surgery (FLACS) is complementing phacoemulsification procedures by improving lens fragmentation and capsulotomy precision. Industry players are investing heavily in R&D to make systems more ergonomic, energy-efficient, and responsive. Such innovations not only boost clinical outcomes but also expand the usability of devices to newer surgeon cohorts. As the field continues to evolve, high-tech phacoemulsification systems are poised to become even more intelligent, less invasive, and tailored to individual surgical needs.

What Role Do Healthcare Infrastructure and Surgical Training Play in Market Penetration?

The spread and adoption of phacoemulsification devices are heavily influenced by the availability of skilled ophthalmic surgeons and the robustness of healthcare infrastructure. In high-income countries, where access to state-of-the-art surgical facilities is more common, phacoemulsification has almost entirely replaced older cataract extraction techniques. However, in many low- and middle-income nations, the lack of trained surgeons and under-equipped surgical centers continues to limit the full-scale adoption of phacoemulsification devices. To bridge this gap, several manufacturers and non-profit organizations are focusing on education and skill-building initiatives through global outreach programs. Structured training modules, virtual reality simulators, and live surgical workshops are helping to train a new generation of ophthalmologists in phacoemulsification techniques. At the same time, the proliferation of ambulatory surgical centers and private eye hospitals in emerging economies is creating new demand for high-quality, cost-effective surgical systems. Insurance coverage and government-sponsored health programs that include cataract surgery have also boosted patient volumes, prompting institutions to invest in phacoemulsification systems. Moreover, standardization of surgical protocols and accreditation requirements is encouraging more hospitals to adopt advanced equipment to meet international care benchmarks. As the global burden of cataract-related blindness grows, expanding surgical capacity and clinician expertise will be essential to enabling widespread adoption of these technologies. With targeted investment in healthcare delivery and skills development, many underpenetrated markets are poised for accelerated growth.

What Are the Key Growth Drivers Powering the Phacoemulsification Devices Market?

The growth in the phacoemulsification devices market is driven by several factors related to technological sophistication, changing demographics, and evolving healthcare delivery models. A primary driver is the rapid aging of the global population, which is leading to a higher incidence of age-related cataracts and consequently, a greater need for surgical intervention. In parallel, the continuous advancement of device functionality such as improved fluidics, real-time surgical analytics, and adaptive energy delivery systems has significantly elevated surgical outcomes and patient safety. Increasing surgeon preference for minimally invasive techniques and precision tools has further solidified phacoemulsification as the preferred method of cataract removal. On the healthcare delivery side, the expansion of private eye clinics, outpatient surgical centers, and specialized ophthalmology networks has amplified the demand for compact, portable, and scalable surgical systems. Consumer behavior is also playing a critical role, with patients increasingly seeking faster recovery, high-definition visual outcomes, and laser-assisted customization. Government-funded cataract elimination programs in countries like India and China, as well as structured reimbursement frameworks in Western nations, have provided financial viability and accessibility to these advanced systems. Additionally, the growing volume of elective cataract procedures and the expansion of cataract surgery into secondary and rural healthcare centers are opening new avenues for device manufacturers. Lastly, the global harmonization of surgical training and device regulation is accelerating time-to-market for new technologies, fueling competitive innovation and broader product availability across regions.

SCOPE OF STUDY:

The report analyzes the Phacoemulsification Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Phacoemulsification Consumables, Phacoemulsification Systems); End-Use (Hospitals End-Use, Clinics End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Alcon
  • Appasamy Associates
  • Bausch + Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos (a Nikon company)
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Phacoemulsification Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cataracts Propels Demand for Phacoemulsification Devices
    • Aging Population Trends Expand the Addressable Market for Minimally Invasive Eye Surgeries
    • Technological Advancements in Ultrasound Energy Delivery Drive Innovation in Phacoemulsification Systems
    • Improved Fluidics and Real-Time Feedback Mechanisms Strengthen the Business Case for Next-Gen Devices
    • Increased Surgical Volume in Emerging Markets Spurs Demand for Compact and Cost-Effective Systems
    • Shift Toward Day Surgery and Ambulatory Cataract Procedures Throws the Spotlight on Portable and Rapid-Cycle Devices
    • Rising Demand for Precision and Customization Drives Integration of Digital Imaging and AI-Enabled Platforms
    • Healthcare Infrastructure Expansion in Asia-Pacific and Latin America Fuels Equipment Procurement Growth
    • Preference for Single-Use Handpieces and Consumables Generates Recurring Revenue Streams
    • Surge in Demand for Premium Intraocular Lenses (IOLs) Supports Growth in Advanced Phaco Systems
    • Increased Focus on Surgical Safety and Efficiency Throws the Spotlight on Ergonomic and User-Centric Designs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Phacoemulsification Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Phacoemulsification Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Phacoemulsification Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION